BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28972180)

  • 1. Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity.
    Arbez N; Ratovitski T; Roby E; Chighladze E; Stewart JC; Ren M; Wang X; Lavery DJ; Ross CA
    J Biol Chem; 2017 Nov; 292(47):19238-19249. PubMed ID: 28972180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats.
    Ratovitski T; O'Meally RN; Jiang M; Chaerkady R; Chighladze E; Stewart JC; Wang X; Arbez N; Roby E; Alexandris A; Duan W; Vijayvargia R; Seong IS; Lavery DJ; Cole RN; Ross CA
    J Proteome Res; 2017 Aug; 16(8):2692-2708. PubMed ID: 28653853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human huntingtin SNP alters post-translational modification and pathogenic proteolysis of the protein causing Huntington disease.
    Martin DDO; Kay C; Collins JA; Nguyen YT; Slama RA; Hayden MR
    Sci Rep; 2018 May; 8(1):8096. PubMed ID: 29802276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.
    Lontay B; Kiss A; Virág L; Tar K
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
    Yin X; Manczak M; Reddy PH
    Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
    Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
    Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.
    Watkin EE; Arbez N; Waldron-Roby E; O'Meally R; Ratovitski T; Cole RN; Ross CA
    PLoS One; 2014; 9(2):e88284. PubMed ID: 24505464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.
    Orr AL; Li S; Wang CE; Li H; Wang J; Rong J; Xu X; Mastroberardino PG; Greenamyre JT; Li XJ
    J Neurosci; 2008 Mar; 28(11):2783-92. PubMed ID: 18337408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease.
    Wang Y; Lin F; Qin ZH
    Neurosci Bull; 2010 Apr; 26(2):153-62. PubMed ID: 20332821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine residues 13 and 16 are key modulators of mutant huntingtin induced toxicity in Drosophila.
    Chatterjee M; Steffan JS; Lukacsovich T; Marsh JL; Agrawal N
    Exp Neurol; 2021 Apr; 338():113463. PubMed ID: 32941796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
    Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA
    EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance.
    Martin DDO; Schmidt ME; Nguyen YT; Lazic N; Hayden MR
    FASEB J; 2019 Mar; 33(3):3190-3197. PubMed ID: 30423259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.
    Ratovitski T; Jiang M; O'Meally RN; Rauniyar P; Chighladze E; Faragó A; Kamath SV; Jin J; Shevelkin AV; Cole RN; Ross CA
    Hum Mol Genet; 2022 May; 31(10):1651-1672. PubMed ID: 34888656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric identification of novel lysine acetylation sites in huntingtin.
    Cong X; Held JM; DeGiacomo F; Bonner A; Chen JM; Schilling B; Czerwieniec GA; Gibson BW; Ellerby LM
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.009829. PubMed ID: 21685499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
    Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR
    J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria?
    Sawa A
    J Mol Med (Berl); 2001 Jul; 79(7):375-81. PubMed ID: 11466559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity.
    Pan Y; Zhu Y; Yang W; Tycksen E; Liu S; Palucki J; Zhu L; Sasaki Y; Sharma MK; Kim AH; Zhang B; Yano H
    J Biol Chem; 2018 Jul; 293(30):11850-11866. PubMed ID: 29891550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
    Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
    Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rab8 Promotes Mutant HTT Aggregation, Reduces Neurodegeneration, and Ameliorates Behavioural Alterations in a Drosophila Model of Huntington's Disease.
    Delfino L; Mason RP; Kyriacou CP; Giorgini F; Rosato E
    J Huntingtons Dis; 2020; 9(3):253-263. PubMed ID: 33044189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.